V-Square Quantitative Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$468K Buy
2,117
+122
+6% +$26.6K 0.04% 365
2026
Q2
$389K Buy
1,995
+592
+42% +$123K 0.04% 388
2026
Q1
$315K Buy
1,403
+100
+8% +$24.9K 0.03% 420
2025
Q4
$314K Buy
+1,303
New +$333K 0.03% 417
2025
Q3
– Sell
-1,747
Closed -$451K – 500
2025
Q2
$451K Buy
1,747
+51
+3% +$12.2K 0.06% 320
2025
Q1
$380K Buy
1,696
+10
+0.6% +$2.34K 0.06% 363
2024
Q4
$386K Sell
1,686
-33
-2% -$7.95K 0.05% 361
2024
Q3
$420K Buy
1,719
+171
+11% +$38.2K 0.06% 344
2024
Q2
$296K Sell
1,548
-335
-18% -$68K 0.05% 366
2024
Q1
$373K Buy
1,883
+575
+44% +$105K 0.05% 330
2023
Q4
$225K Hold
1,308
– – 0.04% 396
2023
Q3
$193K Buy
+1,308
New +$237K 0.09% 363
2023
Q2
– Sell
-915
Closed -$200K – 478
2023
Q1
$200K Buy
+915
New +$199K 0.18% 139

Other funds holding RMD

V-Square Quantitative Management's RMD Position: Q3 2026 in Review

V-Square Quantitative Management increased its ResMed (RMD) stake by 6.1% in Q3 2026, buying an estimated $26.6K and bringing the position to 2,117 shares worth $468K. The position accounts for 0.04% of the portfolio, ranked #365.

V-Square Quantitative Management first reported a position in RMD in Q1 2023 and has held it in 13 quarters since. 134 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • V-Square Quantitative Management held 2,117 shares of ResMed worth $468K as of Q3 2026.
  • V-Square Quantitative Management bought 122 ResMed shares in Q3 2026, an estimated $26.6K.
  • ResMed made up 0.04% of V-Square Quantitative Management's portfolio in Q3 2026, its #365 holding.
  • V-Square Quantitative Management first reported a position in ResMed in Q1 2023 and has held it in 13 quarters since.
  • 134 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on V-Square Quantitative Management's 13F filing for Q3 2026, filed 15 Oct 2026.